SVFD SAVE FOODS INC.

N2OFF: Save Foods to Target California’s Hemp Market

N2OFF: Save Foods to Target California’s Hemp Market

More than half of US hemp flower grown in California recently received Pre-Harvest Regulatory Approval in California allowing Save Foods to treat hemp

Neve Yarak, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- \ (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant-based food, announced today that its subsidiary Save Foods Ltd. (“Save Foods”) is set to target the hemp flower market in California. The Company recently announced that the California Department of Pesticide Regulation approved and registered the use of Save Foods’ pre-harvest treatment, FieldProtect, based on compliance with provisions of California laws and regulations pertaining to pesticide registration.

Hemp flowers are usually treated before harvesting, the new approval allows the Company to address and approach the California market.

A recent report released by the U.S. Department of Agriculture revealed that California led the nation in hemp flower acreage and production in 2022. California produced 56% of all U.S. hemp flower, which is used to extract CBD and other cannabinoids, including intoxicating hemp-derived THC.

In conducted by a third party, Save Foods’ proprietary eco crop protection solution demonstrated up to 90% less disease development in cannabis inflorescences compared to untreated plants. Risk of contamination is present at every stage of the cultivation process. Beyond the health of the plant itself, both medical patients and adult-use consumers may be adversely affected by microbial contaminants. Pathogen contaminants pose an obvious health risk and product recalls may cost companies millions of dollars in lost profit and civil damages.

About N2OFF Inc:

N2OFF Inc. (formerly known as Save Foods, Inc.) is an innovative agri-food tech company that through its three operational arms delivers integrated solutions for improved safety, quality, and sustainability every step of the way from field to fork. Save Foods Ltd., N2OFF's majority-owned Israeli subsidiary, focuses on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination, significantly reduce the use of hazardous chemicals, and prolong fresh produce’s shelf life. NTWO OFF Ltd., N2OFF's majority-owned Israeli subsidiary, contributes to tackling greenhouse gas emissions, offering a pioneering solution to mitigate nitrous oxide (N2O) emissions, a potent greenhouse gas with 265 times the global warming impact of carbon dioxide. NTWO OFF Ltd., aims to promote agricultural practices that are both environmentally friendly and economically viable. N2OFF also has a minority ownership in Plantify Foods, Inc., a Canadian company listed on the TSXV, that offers a wide range of clean-label healthy food options that are nutritious, gluten free, non-allergenic, use whole natural ingredients, and are easy to prepare. For more information on Save Foods Ltd. and NTWO OFF Ltd. visit our website: .

Forward-looking Statements:

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on our current expectations, they are subject to various risks and uncertainties, Actual results, performance, or achievements could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including market conditions as well as those discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K filed with the SEC on February 7, 2024, and in any subsequent filings with the SEC. Except as otherwise required by law, we undertake no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. We are not responsible for the contents of third-party websites.

Investor Relations Contacts:

Michal Efraty



EN
06/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SAVE FOODS INC.

 PRESS RELEASE

N2OFF Completed Merger with Cancer Drug Discovery Company Targeting To...

N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers Neve Yarak, Israel, Oct. 30, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a cleantech company investing in solar energy assets based on the business model, recently announced the closing of the merger with . ("MitoCareX"), a biotech company focused on drug discovery targeting cancer therapeutics, with a range of other potential diseases and disorders, through targeting the mitochondrial SLC25 protein family. MitoCareX is focusing on the devel...

 PRESS RELEASE

N2OFF Announces Closing of Merger with Drug Discovery Company Targetin...

N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer Neve Yarak, Israel, Oct. 23, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a cleantech company investing in solar energy assets based on the business model, announced today the closing of the merger with . ("MitoCareX"), a biotech company focused on drug discovery targeting cancer therapeutics, with a range of other potential diseases and disorders, through targeting the mitochondrial SLC25 protein family. MitoCa...

 PRESS RELEASE

N2OFF Regains Compliance with Nasdaq Minimum Bid Price Requirement

N2OFF Regains Compliance with Nasdaq Minimum Bid Price Requirement Neve Yarak, Israel, Oct. 08, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a cleantech company investing in solar energy assets based on the  business model, announced that it has received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The Company had previously announced on March 28, 2025, that ...

 PRESS RELEASE

N2OFF Stockholders Approve Merger with Drug Discovery Company Targetin...

N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer Neve Yarak, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a cleantech company investing in solar energy assets based on the business model, announced today that a special meeting of stockholders held on September 25, 2025, its stockholders voted on and approved, among others, the proposed acquisition of . ("MitoCareX"), a biotech company focused on drug discovery targeting cancer therapeutics, wi...

 PRESS RELEASE

N2OFF Announces Reverse Stock Split

N2OFF Announces Reverse Stock Split Neve Yarak, Israel, Sept. 18, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.\ (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a clean tech company engaged in sustainable solutions for the energy and agri-tech industries, announced that its Board of Directors has approved a one-for-thirty-five (1-for-35) reverse stock split of its common stock that is scheduled to become effective for Nasdaq purposes on September 22, 2025. Beginning on September 22, 2025, the Company’s common stock will trade on the Nasdaq Capital Market on a split adjusted basis under a new ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch